Date published: 2025-12-18

1-800-457-3801

SCBT Portrait Logo
Seach Input

1600016N20Rik Activators

1600016N20Rik Activators consist of a variety of chemical compounds that enhance the functional activity of 1600016N20Rik through diverse and specific signaling pathways. Forskolin, by increasing adenylate cyclase activity, and consequently intracellular cAMP, activates PKA, which could phosphorylate and enhance the activity of 1600016N20Rik. Similarly, PMA and DiC8 serve as activators of PKC, a kinase that may phosphorylate 1600016N20Rik, thus amplifying its activity. The role of calcium signaling is underscored by Ionomycin, which elevates intracellular calcium and potentially activates CaMKs that could phosphorylate 1600016N20Rik, while sphingosine-1-phosphate signals through its receptors to initiate phosphorylation cascades that enhance 1600016N20Rik activity. The insulin pathway is another conduit, with insulin binding to its receptor, initiating a cascade through PI3K/Akt that might culminate in the activation of 1600016N20Rik.

EGCG, by inhibiting competitive kinases, and retinoic acid, through modulation of gene expression, provide a biochemical environment conducive to the selective activation of 1600016N20Rik. The administration of 8-Br-cAMP, a cAMP analog, ensures the sustained activity of PKA, which is crucial for the phosphorylation and subsequent activation of 1600016N20Rik. Anisomycin, a stress-activated protein kinase activator, introduces another layer of regulation that could enhance 1600016N20Rik via the SAPK/JNK pathway. Additionally, the phosphatase inhibitor Calyculin A preserves the phosphorylated state of 1600016N20Rik, preventing its deactivation. Bisindolylmaleimide I, through PKC inhibition, selectively shifts phosphorylation events towards pathways that involve 1600016N20Rik, subtly enhancing its activity by reducing competing phosphorylations. Collectively, these compounds facilitate the enhancement of 1600016N20Rik's function by engaging with specific cellular signaling pathways, ensuring the protein's activation without direct binding or upregulating its expression levels.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$40.00
$129.00
$210.00
$490.00
$929.00
119
(6)

PMA acts as a direct activator of protein kinase C (PKC) which, upon activation, can phosphorylate multiple substrates including those that could enhance the activity of 1600016N20Rik.

Ionomycin

56092-82-1sc-3592
sc-3592A
1 mg
5 mg
$76.00
$265.00
80
(4)

Ionomycin increases intracellular calcium levels, which can activate calcium/calmodulin-dependent protein kinases (CaMKs) potentially leading to the activation of 1600016N20Rik by phosphorylation.

D-erythro-Sphingosine-1-phosphate

26993-30-6sc-201383
sc-201383D
sc-201383A
sc-201383B
sc-201383C
1 mg
2 mg
5 mg
10 mg
25 mg
$162.00
$316.00
$559.00
$889.00
$1693.00
7
(1)

Sphingosine-1-phosphate activates sphingosine-1-phosphate receptors, which can lead to downstream phosphorylation events enhancing the activity of 1600016N20Rik.

Insulin

11061-68-0sc-29062
sc-29062A
sc-29062B
100 mg
1 g
10 g
$153.00
$1224.00
$12239.00
82
(1)

Insulin activates the insulin receptor, which triggers the PI3K/Akt signaling pathway, potentially resulting in the phosphorylation and enhancement of 1600016N20Rik activity.

(−)-Epigallocatechin Gallate

989-51-5sc-200802
sc-200802A
sc-200802B
sc-200802C
sc-200802D
sc-200802E
10 mg
50 mg
100 mg
500 mg
1 g
10 g
$42.00
$72.00
$124.00
$238.00
$520.00
$1234.00
11
(1)

EGCG inhibits a broad range of kinases, potentially reducing competitive phosphorylation and thus allowing for the preferential activation of 1600016N20Rik by specific kinases.

8-Bromoadenosine 3′,5′-cyclic monophosphate

23583-48-4sc-217493B
sc-217493
sc-217493A
sc-217493C
sc-217493D
25 mg
50 mg
100 mg
250 mg
500 mg
$106.00
$166.00
$289.00
$550.00
$819.00
2
(1)

As a cAMP analog, 8-Br-cAMP elevates PKA activity which could phosphorylate and enhance the activity of 1600016N20Rik.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

Retinoic acid modulates gene expression through its receptors which could lead to upregulation of kinases or phosphatases that specifically enhance the phosphorylation state of 1600016N20Rik.

1,2-Dioctanoyl-sn-glycerol

60514-48-9sc-202397
sc-202397A
10 mg
50 mg
$46.00
$249.00
2
(1)

DiC8 is a synthetic analog of diacylglycerol (DAG) and can activate PKC, potentially leading to phosphorylation and activation of 1600016N20Rik.

Bisindolylmaleimide I (GF 109203X)

133052-90-1sc-24003A
sc-24003
1 mg
5 mg
$103.00
$237.00
36
(1)

Bisindolylmaleimide I is a PKC inhibitor that might lead to the selective activation of pathways involving 1600016N20Rik by reducing PKC-mediated phosphorylation of competitive substrates.

Calyculin A

101932-71-2sc-24000
sc-24000A
10 µg
100 µg
$160.00
$750.00
59
(3)

Calyculin A is a phosphatase inhibitor that could prevent dephosphorylation of 1600016N20Rik, thus maintaining it in an active phosphorylated state.